Europe Multicancer Screening Market Analysis and Forecasts, 2023-2024 and 2032 - Robust Pipeline of Multicancer Screening Tests Poised to Revolutionize Cancer Diagnosis
29 févr. 2024 10h26 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Europe Multicancer Screening Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe...
Global COVID-19 Diagnostics Market Research Report 2024
29 févr. 2024 04h40 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and 5-Year Market Size Outlook" report has been...
Global Monkeypox Diagnostics Market Experiences Surge Amid Health Emergency Declaration
28 févr. 2024 10h58 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts...
Latent TB Diagnostics Market Analysis and Forecasts 2023-2027: Insights into Emerging Technologies and Growth Opportunities - Fostering Strategic Decisions and Industry Leadership
27 févr. 2024 03h58 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis and Forecasts...
Next Generation Cancer Diagnostics Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Janssen, Illumina, Novartis, QIAGEN, and Agilent Technologies Among Others
26 févr. 2024 04h27 HE
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Helicobacter Pylori Non-invasive Testing Market to Exceed USD 788.2 million by 2031, with a CAGR of 4.2%: Transparency Market Research, Inc
22 févr. 2024 05h50 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global helicobacter pylori (H. Pylori) non-invasive testing market is estimated to surge...
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
21 févr. 2024 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the...
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
20 févr. 2024 08h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the...
Precision Diagnostics and Testing Technology Advancements: Innovation is Driving the Era of Value-based Care and Enabling Preventive and Personalized Health
19 févr. 2024 04h26 HE
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Technology Advancements in Precision Diagnostics and Testing" report has been added to ResearchAndMarkets.com's offering. Precision diagnosis in...
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
13 févr. 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...